March 2024 – First Clinical Trial (Phase I) Launched

Adapet officially launched its Phase I clinical usability and safety study, involving a select group of diabetic dogs under veterinary supervision. The trial aimed to explore the user experience from both veterinarians and pet owners, as well as initial data consistency and correlation with traditional glucometers. Results from this phase directly influenced decisions regarding mobile app features, alert thresholds, sensor lifespan optimization, and overall system calibration. It also marked Adapet’s first data set toward medical validation.